Announcements Trials
Browse Landscape

Phase

Phase 3 3Phase 2 2

Status

Completed 2Withdrawn 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 3

Conditions

Urogenital Neoplasms 3Prostatic Neoplasms 3Prostatic Diseases 3Neoplasms by Site 3Neoplasms 3Male Urogenital Diseases 3Genital Neoplasms, Male 3Genital Diseases, Male 3Carcinoma 3Transitional Cell Cancer of Renal Pelvis and Ureter 1

Interventions

pembrolizumab 4Gemcitabine 4padeliporfin 3napabucasin 3Pemetrexed 3Paclitaxel 3Drug Therapy 3Cisplatin 3Carboplatin 3130-nm albumin-bound paclitaxel 3ribociclib 2palbociclib 2Mitomycin 2Gonadotropin-Releasing Hormone 2Fluorouracil 2Bevacizumab 2Anastrozole 2Albumin-Bound Paclitaxel 2AZD9833 2valrubicin 1selinexor 1pralsetinib 1patritumab 1palladium-bacteriopheophorbide 1linifanib 1ipatasertib 1enfortumab vedotin 1camrelizumab 1atezolizumab 1abemaciclib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 3 × Neoplasms by Site × padeliporfin × Clear all
NCT04225299 2020-11-13

Evaluation of Efficacy of TOOKAD® (VTP) Versus Active Surveillance for Intermediate Risk Localized Prostate Cancer

Steba Biotech S.A.

Phase 3 Withdrawn
Genitourinary

Carcinoma, Genital Diseases, Male, Genital Neoplasms, Male, Neoplasms, Neoplasms by Site, Prostatic Diseases, Prostatic Neoplasms, Urogenital Neoplasms, Male Urogenital Diseases

NCT01310894 2019-07-11

PCM301

Steba Biotech S.A.

Phase 3 Completed
413 enrolled
Genitourinary

Carcinoma, Genital Diseases, Male, Genital Neoplasms, Male, Neoplasms, Neoplasms by Site, Prostatic Diseases, Prostatic Neoplasms, Urogenital Neoplasms, Male Urogenital Diseases

NCT01875393 2016-04-19

PCM304

Steba Biotech S.A.

Phase 3 Completed
81 enrolled
Genitourinary

Carcinoma, Genital Diseases, Male, Genital Neoplasms, Male, Neoplasms, Neoplasms by Site, Prostatic Diseases, Prostatic Neoplasms, Urogenital Neoplasms, Male Urogenital Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡